| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 28.200 | 34.133 | 32.938 | 42.209 | 50.255 | 69.011 | 62.853 | 70.282 | 90.938 | 128.310 |
| Total Income - EUR | 28.201 | 34.133 | 32.938 | 42.209 | 50.255 | 73.145 | 63.864 | 70.282 | 90.938 | 128.311 |
| Total Expenses - EUR | 18.251 | 11.421 | 6.328 | 7.191 | 9.843 | 21.716 | 20.019 | 17.299 | 23.823 | 23.839 |
| Gross Profit/Loss - EUR | 9.950 | 22.712 | 26.610 | 35.018 | 40.412 | 51.430 | 43.845 | 52.984 | 67.115 | 104.472 |
| Net Profit/Loss - EUR | 9.103 | 22.284 | 26.280 | 34.384 | 39.910 | 50.934 | 43.229 | 52.298 | 66.224 | 100.700 |
| Employees | 6 | 3 | 3 | 1 | 2 | 2 | 3 | 2 | 2 | 2 |
Check the financial reports for the company - Alcid-Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 209 | 0 | 0 | 0 | 0 | 605 | 2.070 | 1.399 | 3.262 | 1.823 |
| Current Assets | 31.153 | 25.846 | 28.732 | 37.085 | 43.534 | 59.145 | 45.945 | 57.867 | 68.551 | 113.777 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 29.040 | 2.190 | 1.478 | 32.317 | 3.933 | 6.445 | 5.064 | 44.042 | 63.555 | 112.639 |
| Cash | 2.113 | 23.656 | 27.255 | 4.768 | 39.600 | 52.700 | 40.881 | 13.825 | 4.996 | 1.137 |
| Shareholders Funds | 30.681 | 23.215 | 27.156 | 35.244 | 40.753 | 51.761 | 44.038 | 53.109 | 67.194 | 101.665 |
| Social Capital | 45 | 891 | 876 | 860 | 843 | 827 | 809 | 811 | 809 | 804 |
| Debts | 681 | 2.631 | 1.576 | 1.841 | 2.781 | 7.989 | 3.978 | 6.157 | 4.619 | 13.934 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Alcid-Med S.r.l.